The platform functions as a gated exchange where product-level data is accessible only after verification of a user's professional license. Rather than acting as a seller, GreenCore provides the underlying infrastructure—built on Microsoft Azure—to allow licensed counterparties to manage listings, automate inquiries, and process quotes. At launch, the hub hosts over 5,301 product presentations and 24,694 provider records, with specific regulatory pathways separating cosmetic peptide actives from licensed medicinal products.
In section Releases
GreenCore Solutions Launches Gated B2B Peptide Trading Hub
Vancouver-based GreenCore Solutions Corp. has launched A2A-Peptides.ai, an agent-to-agent infrastructure platform designed to facilitate trade for licensed pharmaceutical manufacturers, wholesalers, and prescribers. The service operates across nine jurisdictions, utilizing the Model Context Protocol to connect verified business entities while strictly excluding consumer-facing retail and research-grade stock.
CEO Matthew Keddy emphasized that the infrastructure is designed to provide a verifiable record for industry professionals, ensuring that all interactions remain within the specific regulatory frameworks of the United States, Canada, the European Union, and six other major markets. The system supports AI agents from major providers including Anthropic, OpenAI, and Google, while maintaining a clear separation from consumer pharmacy services. By leveraging its existing experience with the A2A-Cosmetics.ai hub, GreenCore intends to streamline the procurement stack for both beauty brands and pharmaceutical entities within a secure, business-only environment.
Comments (0)
No comments yet. Be the first!